Company profile

SHL Telemedicine Ltd. insider transactions

SHL

Management transactions

4

Shareholding disclosures

103

First disclosure

11.12.2013

Last disclosure

09.07.2026

Company summary

No management purchase or sale disclosed in the last 90 days.

Latest purchase
CHF 49’995

03.12.2025 · Executive member of the board of directors / senior management

Net flow 90 d
CHF 0.00

Buys − sales

Top shareholder
15.199%

Mengke Cai

This page brings together all SHL Telemedicine Ltd. (SHL) insider transactions: 4 management transactions and 103 significant shareholding disclosures published by SIX Exchange Regulation, from 11.12.2013 to 09.07.2026.

Detailed context

This page displays the SHL Telemedicine Ltd. insider transactions as reported to SIX Exchange Regulation, which has published 4 management transactions and 103 significant shareholding disclosures for the company. During the last 90 days, there were 0 purchases totaling CHF 0 and 0 sales totaling CHF 0, with the latest management transaction dated 2025-12-03. The largest declared shareholders by voting rights are Cai Mengke at 49.02%, GF Fund Management Co. Ltd at 49.02%, Eron Shalev at 23.05%, and Himmalaya Cayman Island TMT Fund at 16.1%.

Insider barometer

90 days

No transaction in this window

Latest transaction

03.12.2025

Largest purchase

CHF 694’901

Largest sale

—

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Follow SHL Telemedicine Ltd.’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

SHL Telemedicine Ltd. insider transactions

Latest shareholding disclosures